Eritrea vs Indonesia: Treatment coverage for schistosomiasis
Eritrea
42.8%
in 2023
Indonesia
40.5%
in 2024
Eritrea rank
25th
Indonesia rank
27th
Treatment coverage for schistosomiasis over time
- Eritrea
- Indonesia
How they compare
Eritrea currently reports 42.8% against 40.5% in Indonesia, a difference of 2.3%.
That makes Eritrea's figure about 1.1 times Indonesia's.
The two have swapped places 2 times across 8 shared years of data; in 2014 it was Eritrea ahead.
Eritrea ranks 25th and Indonesia ranks 27th of 45 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.1% | 33.1% | 16.0% | Eritrea |
| 2020s | 48.3% | 13.6% | 34.7% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Eritrea or Indonesia?
- Eritrea, at 42.8% against 40.5% in Indonesia as of 2023.
- What is the difference in treatment coverage for schistosomiasis between Eritrea and Indonesia?
- 2.3%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Indonesia?
- 8 years are reported by both, from 2014 to 2023.
- How do Eritrea and Indonesia rank globally for treatment coverage for schistosomiasis?
- Eritrea ranks 25th and Indonesia ranks 27th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.